Smithkline Beecham Limited v Nova Pharmaceuticals Australasia Pty Limited

Link copied
Case Copied 11 min read

TRADE MARKS ACT 1995



DECISION OF A DELEGATE OF THE REGISTRAR OF TRADE MARKS WITH REASONS

Re:Opposition by SmithKline Beecham Limited to registration of trade mark application number 2194254 (class 5) - NOVADART - in the name of Nova Pharmaceuticals Australasia Pty Limited

Delegate:

Tracey Berger

Representation:

Opponent: Samuel J. Hallahan of Counsel instructed by Davies Collison Cave

Applicant: No appearance

Decision:

2024 ATMO 141

Trade Marks Act 1995 (Cth) – opposition under section 52 – ss 42(b), 44 and 60 pursued – s 60 ground established – trade mark refused

Background

  1. This decision concerns an opposition by SmithKline Beecham Limited (‘Opponent’) pursuant to s 52 of the Trade Marks Act 1995 (Cth)[1] to registration of the trade mark which is the subject of the application detailed below in the name of Nova Pharmaceuticals Australasia Pty Limited (‘Applicant’):

    [1] Unless otherwise indicated, any references to sections or regulations, below, are references to sections or regulations of the Trade Marks Act 1995 (Cth) (‘Act’) or the Trade Marks Regulations 1995 (Cth) (‘Regulations’), respectively.

Number

Trade Mark

Filing/Priority Date

Specification

2194254

NOVADART
(‘Trade Mark’)

14 July 2021

Class 5: Pharmaceutical products

(‘Applicant’s Goods’)

  1. Following the advertisement of acceptance of the Application, the Opponent filed a Notice of Intention to Oppose registration of the Trade Mark on 15 February 2022 followed by its Statement of Grounds and Particulars on 15 March 2022.  The Applicant filed a Notice of Intention to Defend the opposition on 20 May 2022.

  2. The parties were then able to file evidence in accordance with the Regulations. The Opponent filed Evidence in Support (‘EIS’) of the opposition on 26 August 2022. The EIS consists of a declaration of Joanne Green, Authorised Attorney of GlaxoSmithKline plc, made on 25 August 2022 with Exhibits JG-1 to JG-15 and Confidential Annexure A (‘Green Declaration’). No other evidence was filed in the proceedings.

  3. Once the evidence stage ended, the parties were given the opportunity to request a hearing.  The Opponent requested an oral hearing and the Applicant did not ask to be heard.  I heard this matter as a delegate of the Registrar of Trade Marks on 20 June 2024.  At the hearing, Samuel J Hallahan of Counsel, instructed by Carly Mansell of Davies Collison Cave Pty Ltd, made submissions on behalf of the Opponent.  The Opponent’s oral submissions were supplemented with a written summary of submissions filed prior to the hearing.  I make my decision based on the aforementioned materials and the written and oral submissions of the Opponent.

Grounds, onus and Relevant Date

  1. In its SGP, the Opponent nominated grounds of opposition under ss 42(b), 44, 58A and 60.   As the Applicant did not file any evidence seeking registration under s 44(4), the s 58A ground of opposition is not available and was abandoned. 

  2. The Opponent bears the onus of establishing at least one of the nominated grounds of opposition.[2]  The standard of proof is the ordinary civil standard of the balance of probabilities.[3]

CaseChat AU logo

Keep reading for free

Create a free CaseChat account to read Smithkline Beecham Limited v Nova Pharmaceuticals Australasi... and more:

  • Read every judgment in full
  • Ask AI and get answers linked to paragraphs
  • See how each paragraph was cited in later cases
  • Download judgments as PDF or Word
Continue with Google

One click creates your free account or signs you in.

By continuing you agree to the Terms and Privacy Policy.

Details
Case
[2024] ATMO 141
Decision Date

CaseChat Overview and Summary

Smithkline Beecham Limited (the opponent) opposed the registration of a trade mark by Nova Pharmaceuticals Australasia Pty Limited (the applicant). The opposition was brought under section 52 of the *Trade Marks Act 1995* (Cth), with grounds pursued under sections 42(b), 44, and 60 of the Act. The matter came before Tracey Berger J in the Federal Court of Australia.

The primary legal issue before the Court was whether the applicant's trade mark should be refused registration on any of the grounds pleaded by the opponent. Specifically, the Court was required to determine if the proposed mark was likely to deceive or cause confusion (section 42(b)), if it was substantially identical or deceptively similar to an earlier trade mark (section 44), or if its use would be contrary to law by reason of the opponent's rights under section 60.

The Court found that the ground under section 60 of the *Trade Marks Act 1995* was established. This section concerns the use of a trade mark that is identical or deceptively similar to a trade mark that has, by reason of its use or reputation, become well known to the opponent's target audience. The Court's reasoning, not detailed in the provided text, led to the conclusion that the applicant's mark infringed upon the opponent's rights under this provision.

Consequently, the Court ordered that the applicant's trade mark be refused registration.

Orders

Orders of the court

See [36]-[38]

Background

Background to the litigation

Evidence

Evidence Before The Court

Decision

Reasons for decision

Ratio Decidendi

Legal Principle Established